The Diagnostic Value of APTT/Fibrinogen Ratio in Pulmonary Embolism — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

The Diagnostic Value of APTT/Fibrinogen Ratio in Pulmonary Embolism — Stella

Home/Acute Pulmonary Embolism/

View on ClinicalTrials.gov

Recruiting

Back to Acute Pulmonary Embolism trials

Trial locations(1 site)

China

Nanfang hospital of Southern Medical University, Guangzhou, Guangdong

Key details

Sponsor

Nanfang Hospital, Southern Medical University

Enrollment target

~800 participants

Started

January 2018

Primary completion

May 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated April 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.